Overhoff Marita, Sczakiel Georg
Institut für Molekulare Medizin, Universität zu Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany.
EMBO Rep. 2005 Dec;6(12):1176-81. doi: 10.1038/sj.embor.7400535.
The cellular delivery of short interfering RNA (siRNA) is a main hurdle in therapeutic drug development. Here, we describe that phosphorothioate (PTO)-derived oligonucleotides stimulate the physical cellular uptake of siRNA in trans in human cells. This is reflected by an apparent dose-dependent siRNA-mediated suppression of lamin A/C in primary human umbilical vein endothelial cells. The PTO-stimulated cellular uptake in trans is concentration dependent, length dependent, related to the phosphorothioate chemistry but not sequence specific. We provide experimental evidence to support a caveolin-mediated uptake mechanism. In sum, this work strongly suggests the exploration of PTOs as facilitators in the delivery of biologically active siRNA to mammalian cells.
短干扰RNA(siRNA)的细胞递送是治疗药物开发中的一个主要障碍。在此,我们描述了硫代磷酸酯(PTO)衍生的寡核苷酸可刺激人细胞中siRNA的物理性细胞摄取。这在原代人脐静脉内皮细胞中表现为siRNA介导的层粘连蛋白A/C的明显剂量依赖性抑制。PTO刺激的细胞摄取是浓度依赖性、长度依赖性的,与硫代磷酸酯化学性质有关,但不具有序列特异性。我们提供了实验证据来支持小窝蛋白介导的摄取机制。总之,这项工作有力地表明,可探索将PTO用作将生物活性siRNA递送至哺乳动物细胞的促进剂。